Cormorant Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $10.1M | Sell |
|
|||||
|
2021
Q2 | $23.8M | Sell |
|
|||||
|
2021
Q1 | $39.9M | Sell |
|
|||||
|
2020
Q4 | $61.8M | Buy |
|
|||||
|
2020
Q3 | $43.8M | Buy |
|
|||||
|
2020
Q2 | $62.4M | Sell |
|
|||||
|
2020
Q1 | $70.3M | Sell |
|
|||||
|
2019
Q4 | $167M | Sell |
|
|||||
|
2019
Q3 | $65.8M | Buy |
|
|||||
|
2019
Q2 | $76.1M | Buy |
|
|||||
|
2019
Q1 | $52.6M | Sell |
|
|||||
|
2018
Q4 | $37.8M | Buy |
|
|||||
|
2018
Q3 | $54M | Buy |
|
|||||
|
2018
Q2 | $15.7M | Hold |
|
|||||
|
2018
Q1 | $9.23M | Buy |
|
|||||
|
2017
Q4 | $5.66M | Sell |
|
|||||
|
2017
Q3 | $12.1M | Buy |
|